Trial Profile
A Study to Evaluate the Efficacy of Rosuvastatin in Patients with Metabolic Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- 03 Dec 2015 New trial record